Corcept Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2005 - 2019
Net Income	133.66	141.21	106.14	101.42	112.51	106.01	Upgrade
Depreciation & Amortization	1.89	1.34	2.36	3.45	3.48	2.24	Upgrade
Stock-Based Compensation	73.75	61.35	48.94	42.44	42.93	33.54	Upgrade
Other Adjustments	-58.6	-51.13	-38.62	-32.52	9.44	15.54	Upgrade
Change in Receivables	-10.73	-12.85	-10.07	-3.43	-1.43	-6.27	Upgrade
Changes in Inventories	-3.02	0.31	1.27	1.2	3.44	-3.51	Upgrade
Changes in Accounts Payable	4.17	-2.25	5.78	4.76	-3.6	3.16	Upgrade
Changes in Accrued Expenses	37.42	50.78	24.41	5.06	5.22	5.14	Upgrade
Changes in Income Taxes Payable	3.74	3.78	1.21	8.69	0.01	0.01	Upgrade
Changes in Other Operating Activities	-0.09	5.54	-14.38	-10.73	-4.11	-3.89	Upgrade
Operating Cash Flow	182.19	198.07	127.04	120.32	167.89	151.97	Upgrade
Operating Cash Flow Growth	47.24%	55.91%	5.58%	-28.33%	10.48%	11.65%	Upgrade
Capital Expenditures	-1.92	-2.17	-0.14	-0.41	-0.47	-1.24	Upgrade
Purchases of Investments	-506.13	-588.31	-328.75	-355.07	-312.81	-420.11	Upgrade
Proceeds from Sale of Investments	466.6	412.88	419.79	241.15	449.4	302.09	Upgrade
Investing Cash Flow	-41.44	-177.6	90.91	-114.33	136.13	-119.26	Upgrade
Issuance of Common Stock	20.66	9.62	5.81	4.38	16.23	23.23	Upgrade
Repurchase of Common Stock	-46.89	-37.97	-154.53	-21.67	-318.82	-11.01	Upgrade
Net Common Stock Issued (Repurchased)	-26.23	-28.35	-148.72	-17.28	-302.59	12.21	Upgrade
Financing Cash Flow	-168.39	-28.35	-148.72	-17.28	-302.59	12.21	Upgrade
Net Cash Flow	-25.84	-7.89	69.22	-11.29	1.43	44.92	Upgrade
Beginning Cash & Cash Equivalents	-	135.55	66.33	77.62	76.19	31.27	Upgrade
Ending Cash & Cash Equivalents	-25.84	127.67	135.55	66.33	77.62	76.19	Upgrade
Free Cash Flow	180.27	195.9	126.9	119.91	167.42	150.73	Upgrade
Free Cash Flow Growth	-7.98%	54.37%	5.83%	-28.38%	11.07%	11.63%	Upgrade
FCF Margin	25.17%	29.02%	26.31%	29.84%	45.75%	42.59%	Upgrade
Free Cash Flow Per Share	1.52	1.73	1.14	1.03	1.33	1.21	Upgrade
Levered Free Cash Flow	174.17	197.05	126	113.29	116.48	107.92	Upgrade
Unlevered Free Cash Flow	138.13	211.47	143.65	138.96	140.89	155.04	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.